Drug-Induced Cholestasis

被引:45
作者
Bhamidimarri, Kalyan Ram [1 ]
Schiff, Eugene [1 ]
机构
[1] Univ Miami, Miami, FL 33136 USA
关键词
Drugs; Cholestasis; Liver injury; Bile duct injury; Management; INDUCED LIVER-INJURY; BILE-DUCT SYNDROME; INFLAMMATORY-BOWEL-DISEASE; SALT EXPORT PUMP; INTRAHEPATIC CHOLESTASIS; CAUSALITY ASSESSMENT; ORAL MEDICATIONS; UNITED-STATES; CASE-SERIES; HEPATOTOXICITY;
D O I
10.1016/j.cld.2013.07.015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Drug-induced cholestasis manifests as an acute self-limiting injury or as a chronic perpetuating injury, resulting in duct loss and cirrhosis. The number of drugs implicated in drug-induced cholestasis grows every year as new drugs are developed and approved. Other agents such as herbals, nutritional supplements, and complementary and alternative medicines are also reported to cause cholestatic liver injury. Recent literature on molecular transporters involved in bile transport has improved our understanding of patterns of drug-induced liver injury and the mechanisms of cholestasis. This article summarizes the probable offending drugs and the diagnosis and management of drug-induced cholestasis.
引用
收藏
页码:519 / +
页数:14
相关论文
共 60 条
  • [1] Terbinafine and fulminant hepatic failure
    Agarwal, K
    Manas, DM
    Hudson, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16) : 1292 - 1293
  • [2] Akhtar AJ, 2007, J NATL MED ASSOC, V99, P1381
  • [3] Outcome of acute idiosyncratic drug-induced liver injury:: Long-term follow-up in a hepatotoxicity registry
    Andrade, Raul J.
    Lucena, M. Isabel
    Kaplowitz, Neil
    Garcia-Munoz, Beatriz
    Borraz, Yolanda
    Pachkoria, Ketevan
    Garcia-Cortes, Miren
    Fernandez, M. Carmen
    Pelaez, Gloria
    Rodrigo, Luis
    Duran, Jose A.
    Costa, Joan
    Planas, Ramon
    Barriocanal, Anabel
    Guarner, Carlos
    Romero-Gomez, Manuel
    Munoz-Yague, Teresa
    Salmeron, Javier
    Hidalgo, Ramon
    [J]. HEPATOLOGY, 2006, 44 (06) : 1581 - 1588
  • [4] Hepatic safety of antibiotics used in primary care
    Andrade, Raul J.
    Tulkens, Paul M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (07) : 1431 - 1446
  • [5] Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period
    Andrade, RJ
    Lucena, MI
    Fernández, MC
    Pelaez, G
    Pachkoria, K
    García-Ruiz, E
    García-Munoz, B
    González-Grande, R
    Pizarro, A
    Durán, JA
    Jiménez, M
    Rodrigo, L
    Romero-Gomez, M
    Navarro, JM
    Planas, R
    Costa, J
    Borras, A
    Soler, A
    Salmerón, J
    Martin-Vivaldi, R
    [J]. GASTROENTEROLOGY, 2005, 129 (02) : 512 - 521
  • [6] HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
    Andrade, RJ
    Lucena, MI
    Alonso, A
    García-Cortes, M
    García-Ruiz, E
    Benitez, R
    Fernández, MC
    Pelaez, G
    Romero, M
    Corpas, R
    Durán, JA
    Jiménez, M
    Rodrigo, L
    Nogueras, F
    Martín-Vivaldi, R
    Navarro, JM
    Salmerón, J
    de la Cuesta, FS
    Hidalgo, R
    [J]. HEPATOLOGY, 2004, 39 (06) : 1603 - 1612
  • [7] Andrade RJ, 2001, ANN PHARMACOTHER, V35, P783
  • [8] Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease
    Bastida, G
    Nos, P
    Aguas, M
    Beltrán, B
    Rubín, A
    Dasí, F
    Ponce, J
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (09) : 775 - 782
  • [9] Suspected drug-induced liver fatalities reported to the WHO database
    Björnsson, E
    Olsson, R
    [J]. DIGESTIVE AND LIVER DISEASE, 2006, 38 (01) : 33 - 38
  • [10] Drug-Induced Cholestasis
    Bjornsson, Einar S.
    Jonasson, Jon Gunnlaugur
    [J]. CLINICS IN LIVER DISEASE, 2013, 17 (02) : 191 - +